comparemela.com

Latest Breaking News On - Rhone poulenc rorer - Page 5 : comparemela.com

Ymmunobio Appoints Dr Michel Janicot as Chief Development Officer

BioPharma

Basel stadtFrance generalRhone poulenc rorerKatrin rupallaJmi onconsultingMichel janicotUniversity of parisChief development officerYmmunobio founderManaging director

Nu Skin Chief Scientific Officer Dr Joseph Y Chang Receives Award for Outstanding Contributions in Personalized Nutrition

/PRNewswire/ Nu Skin Enterprises (NYSE: NUS), a global beauty and wellness leader, today announced that its Chief Scientific Officer Dr. Joseph Y. Chang.

New yorkUnited statesJosephy changRhone poulenc rorerUniversity of californiaPortsmouth universityInflammation research associationAmerican association for the advancement of scienceArthritis foundationReticuloendothelial societyRhyz incBinary therapeutics incDepartment of nutritionOsteoarthritis sciences incNu skin force for good foundationNu skin enterprises

Nu Skin Chief Scientific Officer Dr Joseph Y Chang Receives Award for Outstanding Contributions in Personalized Nutrition

/PRNewswire/ Nu Skin Enterprises (NYSE: NUS), a global beauty and wellness leader, today announced that its Chief Scientific Officer Dr. Joseph Y. Chang.

New yorkUnited statesJosephy changRhone poulenc rorerUniversity of californiaPortsmouth universityInflammation research associationAmerican association for the advancement of scienceArthritis foundationReticuloendothelial societyRhyz incBinary therapeutics incDepartment of nutritionOsteoarthritis sciences incNu skin force for good foundationNu skin enterprises

Duality announced the appointment of Dr Yver as Chairman of SAB

/PRNewswire/ Duality Biotherapeutics, Inc. ("Duality" or "the Company") today announced the appointment of Dr. Antoine Yver as Chairman of SAB. Dr. Antoine.

France generalUnited statesJohn zhuRhone poulenc rorerDaiichi sankyoAntoine yverDuality biotherapeutics incDevelopment at centessa pharmaceuticals ltdAventis groupUniversity of parisAntibody drug conjugatesCentessa pharmaceuticalsExecutive vice presidentGlobal headCancer enterpriseSenior vice president

Duality announced the appointment of Dr Yver as Chairman of SAB

PRINCETON, N. J. and SHANGHAI, SUZHOU, China, Oct. 3, 2022 /PRNewswire/ Duality Biotherapeutics, Inc. ( Duality or the Company ) today announ.

France generalUnited statesJohn zhuRhone poulenc rorerDaiichi sankyoAntoine yverDuality biotherapeutics incDevelopment at centessa pharmaceuticals ltdAventis groupUniversity of parisAntibody drug conjugatesCentessa pharmaceuticalsExecutive vice presidentGlobal headCancer enterpriseSenior vice president

vimarsana © 2020. All Rights Reserved.